tiprankstipranks
Trending News
More News >
Aspire Biopharma Holdings (ASBP)
NASDAQ:ASBP
US Market

Aspire Biopharma Holdings (ASBP) Income Statement

Compare
138 Followers

Aspire Biopharma Holdings Income Statement

Last quarter (Q3 2025), Aspire Biopharma Holdings's total revenue was $1.94K, an increase of Infinity% from the same quarter last year. In Q3, Aspire Biopharma Holdings's net income was $-1.85M. See Aspire Biopharma Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 3.09M$ 358.59K$ 596.49K$ 25.48K
Depreciation and Amortization
$ 0.00$ 0.00$ 0.00$ 27.79K
EBITDA
$ -11.65M$ -358.59K$ -596.49K$ -25.48K
Operating Income
$ -3.09M$ -358.59K$ -596.49K$ -25.48K
Other Income/Expenses
$ -9.45M$ 0.00$ 0.00$ 5.00
Pretax Income
$ -12.54M$ -358.59K$ -596.49K$ -25.48K
Net Income
$ -12.54M$ -359.07K$ -597.12K$ -25.48K
Per Share Metrics
Basic EPS
$ -0.26$ -0.01$ -0.01$ 0.00
Diluted EPS
$ -0.26$ -0.01$ -0.01$ 0.00
Weighted Average Shares Outstanding
47.64M 45.94M 45.94M 6.25M
Weighted Average Shares Outstanding (Diluted)
47.64M 45.94M 45.94M 6.25M
Currency in USD

Aspire Biopharma Holdings Earnings and Revenue History